SignalTech/AI

NOVO NORDISK WILL USE ANTHROPIC’S CLAUDE FOR DRUG RESEARCH - WSJ

Novo Nordisk adopting Anthropic's Claude for drug research signals AI-pharma catalyst.

What changed

Novo Nordisk adopting Anthropic's Claude for drug research signals AI-pharma catalyst.

Why it matters

Novo Nordisk adopting Anthropic's Claude for drug research signals AI-pharma catalyst. — impact context not separately stored; see What changed.

Sources